EICHOR
● Active Not Recruiting
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Condition: Atopic Dermatitis · Eczema · Sponsor: Eli Lilly and Company
About this study
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18 years of age with moderate-to-severe atopic dermatitis (AD).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (85)
| Clinical Research Center of Alabama | Birmingham, Alabama, United States | — |
| Phoenix Children's Hospital | Phoenix, Arizona, United States | — |
| Arkansas Research Trials | North Little Rock, Arkansas, United States | — |
| First OC Dermatology | Fountain Valley, California, United States | — |
| Antelope Valley Clinical Trials | Lancaster, California, United States | — |
| Dermatology Research Associates | Los Angeles, California, United States | — |
| Integrative Skin Science and Research | Sacramento, California, United States | — |
| Rady's Children Hospital San Diego - Dermatology | San Diego, California, United States | — |
| UConn Health | Farmington, Connecticut, United States | — |
| Solutions Through Advanced Research | Jacksonville, Florida, United States | — |
| ForCare Clinical Research | Tampa, Florida, United States | — |
| Treasure Valley Medical Research | Boise, Idaho, United States | — |
+ 73 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05559359